While personalized medicine currently comes with a hefty price tag, speakers at MedCity's Converge conference say that that it will come down as adoption becomes more widespread.
Registering provides access to this and other free content.
Already have an account?Login Now.
The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.
Jun Wang, the chief executive of BGI, has stepped down.
In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.
The New York Times' George Johnson muses on cancer's roots in multicellularity.